Freebase is currently in read-only mode
Raven biotechnologies en
Raven biotechnologies, inc. is focused on the discovery of new drug targetsfor life-threatening conditions and the development of antibody therapeuticproducts to treat them. To drive the discovery, development andcommercialization of our products, Raven has assembled a world-class team withexceptionally rich industry experience in research, clinical development, andregulatory affairs. Raven also has deep expertise in protein therapeuticproduction and manufacturing antibodies for clinical development as well ascapabilities for scale-up of biopharmaceutical manufacturing of drug forclinical trials. [ - ]
Freebase Commons Metaweb System Types /type
- -
- Raven biotechnologies, inc. is focused on the discovery of new drug targetsfor life-threatening conditions and the development of antibody therapeuticproducts to treat them. To drive the discovery, development andcommercialization of our products, Raven has assembled a world-class team withexceptionally rich industry experience in research, clinical development, andregulatory affairs. Raven also has deep expertise in protein therapeuticproduction and manufacturing antibodies for clinical development as well ascapabilities for scale-up of biopharmaceutical manufacturing of drug forclinical trials.
- -
- -
- -
- -
- -
|
- -
- -
| Person | Title | From | To |
|---|---|---|---|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
| number | date | Source |
|---|---|---|
|
||
| Investor | Investment Round | Date | Currency | Amount |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
| Space | Brand | Portion |
|---|---|---|
|
||
- -
- -
| Currency | Amount | Valid Date | Source |
|---|---|---|---|
|
|||
Freebase Commons Organization /organization
- -
- -
| Street Address | City/Town | State/Province/Region | Postal Code |
|---|---|---|---|
|
- 2005
| Person | Title | Role | From | To |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- -
- -
| Organizations merging | Date | Became organization |
|---|---|---|
|
|
| Organizations merging | Date |
|---|---|
|
|
| Parent organization | Date |
|---|---|
|
|
| Child organization | Date |
|---|---|
|
|
| Parent | From | To |
|---|---|---|
|
||
| Child | From | To |
|---|---|---|
|
||
- -
- -
- -
| Previous name | Start date | End date |
|---|---|---|
|
||
- -
| Acquiring organization | Date | Divisions formed |
|---|---|---|
|
||
| Organization acquired | Date | Divisions formed |
|---|---|---|
|
||
| Person | Role | Title | From | To |
|---|---|---|---|---|
|
||||
- -
| Email address | Category |
|---|---|
|
|
| Country Code | Number | Category | Service location | Note |
|---|---|---|---|---|
|
||||
User Domain BioVenturist /base/bioventurist
- -
- -
| Investment round | Amount raised | Currency | Date | Investors | web reference |
|---|---|---|---|---|---|
|
|||||
- -